Consequently, it will be informative to test whether identifying and blocking cancer-specific interactions between histone variants and chaperones, such as DAXX binding to CENP-A, or between chaperones and chromatin regulatory complexes can serve as a potent method to singularly attack cancer-specific networks while sparing normal cells. This evidence concerns the gene DAXX and cancer.